文献速递乳腺乳腺X线US

对比增强能谱乳腺X线摄影后常规乳腺超声检查的必要性

Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography.
PubMed 文献 · Clin Radiol · 2018-07-02

回顾性收集2012年5月至2016年2月同时行对比增强能谱乳腺X线摄影(CESM)和乳腺超声(US)的筛查与诊断病例,分别赋予BI-RADS评分。87个病灶活检,37个(43%)恶性。CESM可疑与恶性活检相关(p<0.0001),US可疑不相关(p=0.985)。CESM敏感度97%(36/37),US 92%(34/37);CESM特异度40%,显著高于US的8%。

要点

  • CESM可疑时,后续US和活检是合适的。
  • CESM BI-RADS 3时,建议(弱推荐)与US对照。
  • CESM良性表现时,常规US的价值存疑,可能导致不必要的良性活检。

核心结论

  • CESM可疑时行US和活检是合适的;CESM BI-RADS 3时建议(弱推荐)与US对照;CESM良性表现时常规US的价值存疑,可能导致不必要的良性活检。

研究设计与样本

  • 回顾性研究,连续收集2012年5月至2016年2月同时行CESM和乳腺US的筛查与诊断病例;放射科医生分别对CESM和US赋予BI-RADS评分,评分分为正常/良性表现(BI-RADS 1、2)、可能良性短期随访(BI-RADS 3)和可疑表现(BI-RADS 0、4、5)三类;任一检查发现可疑病灶者行活检;共87个病灶活检。

诊断标准与关键数值

  • CESM可疑表现与恶性活检相关(p<0.0001),US可疑表现与恶性活检不相关(p=0.985);37个恶性活检中CESM敏感度97%(36/37),US敏感度92%(34/37);CESM特异度40%,显著高于US的8%;恶性活检中无CESM表现为正常/良性者。

临床应用与阅片要点

  • CESM可疑时应行后续US和活检;CESM BI-RADS 3时建议(弱推荐)与US对照;CESM良性表现时常规US的价值存疑,可能导致不必要的良性活检。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate whether breast ultrasound (US) is routinely indicated following contrast-enhanced spectral mammography (CESM).

MATERIALS AND METHODS: Consecutive screening and diagnostic CESM examinations with concurrent breast US were collected retrospectively (May 2012 to February 2016). Radiologists assigned a separate Breast Imaging-Reporting and Data System (BIRADS) score for CESM and for US. BIRADS scores were grouped into three categories: normal/benign appearing (BIRADS 1, 2); probably benign, short-term follow-up (BIRADS 3); or suspicious appearing (BIRADS 0, 4, 5). Patients with a suspicious-appearing lesion in either US or CESM underwent biopsy. The associations between malignant pathology with either suspicious-appearing CESM or suspicious-appearing US were calculated. The sensitivities and specificities of CESM and US were analysed.

RESULTS: Eighty-seven lesions were biopsied, 37 (43%) biopsies were malignant and 50 (57%) were benign. Although suspicious-appearing CESM was associated with malignant biopsies (p<0.0001), suspicious-appearing US was not (p=0.985). Among 37 malignant biopsies, CESM had a sensitivity of 97% (36/37 lesions), compared to 92% (34/37 lesions) with US. None of the malignant biopsies were normal/benign appearing with CESM. One case of follow-up CESM was suspicious-appearing at US and proved to be malignant on biopsy. The specificity of CESM was 40%, which was significantly higher than US at 8%.

CONCLUSION: When CESM is suspicious appearing, subsequent US and biopsy is appropriate. With a CESM BIRADS 3, correlation with US is suggested. If the CESM is benign appearing, the routine use of US is questionable, as it may lead to unnecessary benign biopsies.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Klang E, Krosser A, Amitai MM, et al. Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography. Clin Radiol. 2018. PMID: 30041953. doi:10.1016/j.crad.2018.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。